| The antibodie's description: |
Apo-AV, ApoA-V, Apolipoprotein A5, Regeneration-associated protein 3 antibody, anti-Apolipoprotein A-V |
| The antigen used: |
Apo-AV, ApoA-V, Apolipoprotein A5, Regeneration-associated protein 3 antigen, epitope of the human Apolipoprotein A-V |
| Gene name: |
Apo-AV, ApoA-V, Apolipoprotein A5, Regeneration-associated protein 3, Apolipoprotein A-V |
| Reactivity: |
human |
| Research field: |
Cancer/Apoptosis |
| Related products: |
APOA5 rabbit polyclonal antibodies |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bluegen antibodies they should be stored frozen at - 24° |
| Gene target: |
APOA5 |
| Short name: |
anti-APOA5 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
antibody to-apolipoprotein A-V (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APOA5 and IDBG-630769 and ENSBTAG00000019764 and 538914, APOA5 and IDBG-72432 and ENSG00000110243 and 116519, Apoa5 and IDBG-161348 and ENSMUSG00000032079 and 66113, Extracellular, lipoprotein particle receptor binding, this GO :0005543 and phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0006641 and triglyceride metabolic process and biological process this GO :0006869 and lipid transport and biological process this GO :0008047 and enzyme activator activity and molecular function this GO :0008201 and heparin binding and molecular function this GO :0008289 and lipid binding and molecular function this GO :0009725 and response to hormone and biological process this GO :0010898 and positive regulation of triglyceride catabolic process and biological process this GO :0010902 and positive regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0019433 and triglyceride catabolic process and biological process this GO :0019899 and enzyme binding and molecular function this GO :0031100 and organ regeneration and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0035473 and lipase binding and molecular function this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042246 and tissue regeneration and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0044255 and cellular lipid metabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045723 and positive regulation of fatty acid biosynthetic process and biological process this GO :0048260 and positive regulation of receptor-mediated endocytosis and biological process this GO :0050750 and low-density lipoprotein particle receptor binding and molecular function this GO :0050996 and positive regulation of lipid catabolic process and biological process this GO :0051006 and positive regulation of lipoprotein lipase activity and biological process this GO :0055090 and acylglycerol homeostasis and biological process this GO :0060229 and lipase activator activity and molecular function this GO :0060230 and lipoprotein lipase activator activity and molecular function this GO :0070325 and lipoprotein particle receptor binding and molecular function this GO :0070328 and triglyceride homeostasis and biological process, this GO :0005543 : phospholipid binding, this GO :0005543 : phospholipid binding and also this GO :0008047 : enzyme activator activity and also this GO :0008201 : heparin binding and also this GO :0008289 : lipid binding and also this GO :0019899 : enzyme binding and also this GO :0031210 : phosphatidylcholine binding and also this GO :0035473 : lipase binding and also this GO :0050750 : low-density lipoprotein particle receptor binding and also this GO :0060229 : lipase activator activity and also this GO :0060230 : lipoprotein lipase activator activity and also this GO :0070325 : lipoprotein particle receptor binding, this GO :0008047 : enzyme activator activity, this GO :0008201 : heparin binding, this GO :0008289 : lipid binding, this GO :0019899 : enzyme binding, this GO :0031210 : phosphatidylcholine binding, this GO :0035473 : lipase binding, this GO :0050750 : low-density lipoprotein particle receptor binding, this GO :0060229 : lipase activator activity, this GO :0060230 : lipoprotein lipase activator activity, this GO :0070325 : lipoprotein particle receptor binding, apolipoprotein A-V |
| Identity: |
17288 |
| Gene: |
APOA5 |
More about : APOA5 |
| Long gene name: |
apolipoprotein A5 |
| Synonyms gene name: |
apolipoprotein A-V |
| Synonyms: |
RAP3 APOA-V |
| Locus: |
11q23, 3 |
| Discovery year: |
2001-12-11 |
| GenBank acession: |
AF202889 |
| Entrez gene record: |
116519 |
| Pubmed identfication: |
11588264 11577099 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000046116 |